Figure 3. Percentage Of Patients (y-axis) Attaining A Phosphorus Reduction From Baseline (mg/dl) At Least As Great As The Value Of The X-axis. (Sevelamer Fig1)
Sevelamer Carbonate Powder, For Suspension
Product Images NDC 65862-930
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 65862-930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 4. Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Sevelamer Fig2)
The given text seems to be a graphical representation of the Reduction in Serum Phosphorus with Sevelamer Hydrochloride™ treatment. It shows a bar graph with the percentage of patients and their reduction from baseline. The text also mentions the term 'anesg®' and '2X,' but it is not clear what those refer to in the context of the graph. Overall, the description is regarding the graph that demonstrates the effect of Sevelamer Hydrochloride™ on the reduction of serum phosphorus levels of patients.*
Package Label-principal Display Panel (0.8 g Pouch Carton)
This appears to be a chart or graph showing some data related to the change in phosphorus levels over time in a study involving Sevelamer Hydrochloride as the active control. The numbers on the vertical axis go up to 22, and there is a percentage symbol next to the number 3. The horizontal axis is labeled "Study Week" and goes up to 52 weeks. Without more context or clearer images, it is difficult to provide a more detailed description.*
Package Label-principal Display Panel (2.4 g Pouch Carton)
This appears to be a medication label for Sevelamer Carbonate Oral Suspension. The medication comes in 90 pouches, each containing 0.8 grams of the drug. The medication is mixed with water and taken orally. The label includes information about dosing, storage, and manufacturer contact information. There is also mention of an orange flavor.*
Sevelamer Fig5
Chemical Structure (Sevelamer Str)
This text provides a chemical structure diagram of Sevelamer Carbonate, a medication used to treat high levels of phosphorus in the blood of people with chronic kidney disease who are on dialysis. It includes a description of the various chemical groups that make up the molecule, including primary amine groups and crosslinking groups, as well as an indication of the extended polymer network present in the compound.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
